Efficacy of p16 and Ki‑67 immunostaining in the detection of squamous intraepithelial lesions in a high‑risk HPV group

Lim,Sharon; Lee,Mi Ja; Cho,Inju; Hong,Ran; Lim,Sung  Chul

doi:10.3892/ol.2015.4071

Efficacy of p16 and Ki‑67 immunostaining in the detection of squamous intraepithelial lesions in a high‑risk HPV group

Authors:
- Sharon Lim
- Mi Ja Lee
- Inju Cho
- Ran Hong
- Sung Chul Lim
View Affiliations

Affiliations: Department of Pathology, College of Medicine, Chosun University, Gwangju Metropolitan City 501‑759, Republic of Korea
Published online on: December 31, 2015 https://doi.org/10.3892/ol.2015.4071
Pages: 1447-1452

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

p16 and Ki‑67 immunohistochemistry can be used as an ancillary method for the diagnosis of squamous intraepithelial lesion (SIL) versus atrophic change and atypical squamous metaplasia. The aim of the present study was to evaluate the efficacy of these two immunohistochemical markers in the accurate interpretation of cervical biopsies and correlate this data with human papilloma virus (HPV) infection status. The study included 103 formalin‑fixed cervical punch and cone biopsy samples, with corresponding HPV DNA test data. Histopathological staining with hematoxylin and eosin, and immunohistochemical staining for p16 and Ki‑67 were reviewed by two pathologists. The positivity of p16 and Ki‑67 increased significantly with the severity of the cervical lesion in patients with a high‑risk‑HPV (HR‑HPV) infection status (P<0.001). However, there was discordance in the HPV‑negative group. Furthermore, concomitant diffuse, strong and block positive staining of p16, and a high Ki‑67 index were implicated in high‑grade SIL in the HR‑HPV group. Thus, the two markers were efficient in advancing the diagnostic accuracy of cervical biopsies in the HR‑HPV group; however, application of immunohistochemical results should be carefully considered in the HPV‑negative group.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
2	Schiffman M, Castle PE, Jeronimo J, Rodriguez AC and Wacholder S: Human papillomavirus and cervical cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
3	Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ and Solomon D: 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis. 11:223–239. 2007. View Article : Google Scholar : PubMed/NCBI
4	Wright TC Jr, Cox JT, Massad LS, Twiggs LB and Wilkinson EJ: ASCCP-Sponsored Consensus Conference: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 287:2120–2129. 2002. View Article : Google Scholar : PubMed/NCBI
5	Kalof AN and Cooper K: p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 13:190–194. 2006. View Article : Google Scholar : PubMed/NCBI
6	Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al: p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 26:1389–1399. 2002. View Article : Google Scholar : PubMed/NCBI
7	Horn LC, Reichert A, Oster A, Arndal SF, Trunk MJ, Ridder R, et al: Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 32:502–512. 2008. View Article : Google Scholar : PubMed/NCBI
8	Ma L, Fisk JM, Zhang RR, Ulukus EC, Crum CP and Zheng W: Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia. Am J Surg Pathol. 28:1474–1484. 2004. View Article : Google Scholar : PubMed/NCBI
9	Aoyama C, Liu P, Ostrzega N and Holschneider CH: Histologic and immunohistochemical characteristic of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix. Am J Clin Pathol. 123:699–706. 2005. View Article : Google Scholar : PubMed/NCBI
10	Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, et al: Immunohistochemical expression of p16INK4A is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol. 19:384–391. 2006. View Article : Google Scholar : PubMed/NCBI
11	Pinto AP, Schlecht NF, Woo TY, Crum CP and Cibas ES: Biomarker (ProExC, p16INK4A, and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol. 21:1067–1074. 2008. View Article : Google Scholar : PubMed/NCBI
12	Sanati S, Huettner P and Ylagan LR: Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol. 29:79–87. 2010. View Article : Google Scholar : PubMed/NCBI
13	Walts AE and Bose S: p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia. Hum Pathol. 40:957–964. 2009. View Article : Google Scholar : PubMed/NCBI
14	Cameron RI, Maxwell P, Jenkins D and McCluggage WG: Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology. 41:313–321. 2002. View Article : Google Scholar : PubMed/NCBI
15	Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al: The biology and life-cycle of human papillomaviruses. Vaccine. 30(Suppl 5): F55–F70. 2012. View Article : Google Scholar : PubMed/NCBI
16	Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR and Howley PM: Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA. 93:4350–4354. 1996. View Article : Google Scholar : PubMed/NCBI
17	Guo M, Baruch AC, Silva EG, Jan YJ, Lin E, Sneige N and Deavers MT: Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol. 135:212–220. 2011. View Article : Google Scholar : PubMed/NCBI
18	Hitchcock CL: Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Am J Clin Pathol. 96:444–446. 1991.PubMed/NCBI
19	McCluggage WG: Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology. 39:97–111. 2007. View Article : Google Scholar : PubMed/NCBI
20	Cina SJ, Richardson MS, Austin RM and Kurman RJ: Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol. 10:176–180. 1997.PubMed/NCBI
21	Reich O, Regauer S, Marth C, Schmidt D, Horn LC, Dannecker C, Menton M and Beckmann MW: Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract. Geburtshilfe Frauenheilkd. 75:1018–1020. 2015. View Article : Google Scholar : PubMed/NCBI
22	Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS and Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA. 297:813–819. 2007. View Article : Google Scholar : PubMed/NCBI
23	Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al: The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 16:205–242. 2012. View Article : Google Scholar : PubMed/NCBI
24	Reuschenbach M, Seiz M, von Knebel Doeberitz C, Vinokurova S, Duwe A, Ridder R, et al: Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells. Int J Cancer. 130:388–394. 2012. View Article : Google Scholar : PubMed/NCBI
25	Kiernan JA: Histological and Histochemical Methods: Theory and Practice. 12:(3rd). Oxford, UK: Butterworth-Heinemann. 1999.
26	Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB and Koutsky LA: p16INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 16:665–673. 2003. View Article : Google Scholar : PubMed/NCBI
27	Liang J, Mittal KR, Wei JJ, Yee H, Chiriboga L and Shukla P: Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol. 26:71–75. 2007. View Article : Google Scholar : PubMed/NCBI
28	Pavlakis K, Messini I, Athanassiadou S, Kyrodimou E, Pandazopoulou A, Vrekoussis T and Stathopoulos EN: Endocervical glandular lesions: a diagnostic approach combining a semiquantitative scoring method to the expression of CEA, MIB-1 and p16. Gynecol Oncol. 103:971–976. 2006. View Article : Google Scholar : PubMed/NCBI
29	Qiao X, Bhuiya TA and Spitzer M: Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. Low Genit Tract Dis. 9:100–107. 2005. View Article : Google Scholar
30	Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T and Ridder R: European CINtec Histology Study Group: Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 133:395–406. 2010. View Article : Google Scholar : PubMed/NCBI
31	Doeberitz MV and Vinokurova S: Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. Arch Med Res. 40:435–442. 2009. View Article : Google Scholar : PubMed/NCBI
32	von Knebel Doeberitz M: New markers for cervical dysplasia to visualise the genomic created by aberrant oncogenic papillomavirus infections. Eur J Cancer. 38:2229–2242. 2002. View Article : Google Scholar : PubMed/NCBI